Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2003-9-3
pubmed:abstractText
AP-2 complexes are key components in clathrin-mediated endocytosis (CME). They trigger clathrin assembly, interact directly with cargo molecules, and recruit a number of endocytic accessory factors. Adaptor-associated kinase (AAK1), an AP-2 binding partner, modulates AP-2 function by phosphorylating its mu2 subunit. Here, we examined the effects of adenoviral-mediated overexpression of WT AAK1, kinase-dead, and truncation mutants in HeLa cells, and show that AAK1 also regulates AP-2 function in vivo. WT AAK1 overexpression selectively blocks transferrin (Tfn) receptor and LRP endocytosis. Inhibition was kinase independent, but required the full-length AAK1 as truncation mutants were not inhibitory. Although changes in mu2 phosphorylation were not detected, AAK1 overexpression significantly decreased the phosphorylation of large adaptin subunits and the normally punctate AP-2 distribution was dispersed, suggesting that AAK1 overexpression inhibited Tfn endocytosis by functionally sequestering AP-2. Surprisingly, clathrin distribution and EGF uptake were unaffected by AAK1 overexpression. Thus, AP-2 may not be stoichiometrically required for coat assembly, and may have a more cargo-selective function in CME than previously thought.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-10087264, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-10406795, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-10430869, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-10436022, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-10575017, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-10611976, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-10887964, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-11044456, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-11257904, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-11516654, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-11517213, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-11577110, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-11687498, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-11877457, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-11877461, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-12010461, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-12086608, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-12234931, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-12353027, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-12952941, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-1447294, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-7962076, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-8400457, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-8408206, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-8416994, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-8837779, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-8909539, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-9388255, http://linkedlifedata.com/resource/pubmed/commentcorrection/12952931-9864361
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0021-9525
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
162
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
773-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
Differential requirements for AP-2 in clathrin-mediated endocytosis.
pubmed:affiliation
The Scripps Research Institute, La Jolla, CA 92037, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.